Načítá se...
Likelihood-Based Methods for Assessing Principal Surrogate Endpoints in Vaccine Trials
When evaluating principal surrogate biomarkers in vaccine trials, missingness in potential outcomes requires prediction using auxiliary variables and/or augmented study design with a close-out placebo vaccination (CPV) component. The estimated likelihood approach, which separates the estimation of b...
Uloženo v:
| Vydáno v: | Stat Biosci |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537791/ https://ncbi.nlm.nih.gov/pubmed/33033531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12561-019-09239-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|